BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
BRAF
,
nitric oxide metabolic process
,
Hepatitis
,
Prostate
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NKG2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vesicular stomatitis Indiana virus disease
Listeriosis
Meningitis
Viral infections of the central nervous system
Spotted fevers
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
OVA-8
Ifna protein, mouse
N,N-dimethyl-4-anisidine
urolithin A
gp50 protein, Schistosoma
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
LEP
MIR34A
PIGA
BPTF
STAT5B
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Combination of NKG2A and PD-1 Blockade Improves Radiotherapy Response in Radioresistant Tumors.
Monalizumab: inhibiting the novel immune checkpoint NKG2A.
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
Echinococcus multilocularis inoculation induces NK cell functional decrease through high expression …
Tissue-protective effects of NKG2A in immune-mediated clearance of virus infection.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irra…
Romidepsin Plus 3BNC117 Phase 2a Study
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ